Efficacy and Safety of Docetaxel in Elderly Patients With Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Limited data are available about the tolerability and clinical outcomes of elderly patients with metastatic castration-resistant prostate cancer (mCRPC) who are treated with docetaxel. We evaluated the efficacy and safety of docetaxel as first-line chemotherapy for patients with mCRPC who w...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Glob Oncol
Glavni autori: Maia, Manuel Caitano, Pereira, Allan A. Lima, Lage, Liana Valente, Fraile, Natalia Moreno, Vaisberg, Victor Van, Kudo, Guilherme, Barroso-Sousa, Romualdo, Bastos, Diogo Assed, Dzik, Carlos
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2017
Teme:
ORIGINAL REPORTS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6180794/
https://ncbi.nlm.nih.gov/pubmed/30241182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.2016.007807
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items